Loading…
Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet
Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of th...
Saved in:
Published in: | International journal of pharmaceutics 2010-02, Vol.386 (1), p.201-207 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3 |
---|---|
cites | |
container_end_page | 207 |
container_issue | 1 |
container_start_page | 201 |
container_title | International journal of pharmaceutics |
container_volume | 386 |
creator | Mourão, Samanta C. da Silva, Cristiane Bresolin, Tania M.B. Serra, Cristina H.R. Porta, Valentina |
description | Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37
°C using apparatus II at 50, 75 or 100
rpm. Dissolution efficiency (DE),
T
50 and
T
90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of
T
50 and
T
90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50
rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions. |
doi_str_mv | 10.1016/j.ijpharm.2009.11.022 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733863728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517309008242</els_id><sourcerecordid>733863728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</originalsourceid><addsrcrecordid>eNqFkE1v1TAQRS0Eoo_CTwBlg7pKGH_ETlYIlVKQKiFVZW3NsyfUT0n8sB1E_z2pXgTLrmZz7p2rw9hbDg0Hrj8cmnA43mOaGgHQN5w3IMQztuOdkbVURj9nO5Cmq1tu5Bl7lfMBALTg8iU7432veK_Ujt1-DjnHcSkhztURE05UKOVqiKnK0YdlqnxwYxxoRle7OBcMc5h_VvcPxxQnGseYqZqwpPCnKrgfqbxmLwYcM73Z7jn78eXq7vJrffP9-tvlp5vayV6VugdBgoZWc1QetNYGUQo_dEYDAmlQQsgWBmr30GnX806hVtRz77XRwslzdnHqXYf8WigXO4Xs1kU4U1yyNVJ2WhrRrWR7Il2KOSca7DGFCdOD5WAfbdqD3WzaR5uWc7vaXHPvtg_LfiL_P7XpW4H3G4DZ4TgknF3I_zghlGkFh5X7eOJo9fE7ULLZBZod-ZDIFetjeGLKX5L-lmc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733863728</pqid></control><display><type>article</type><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><source>ScienceDirect Journals</source><creator>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</creator><creatorcontrib>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</creatorcontrib><description>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37
°C using apparatus II at 50, 75 or 100
rpm. Dissolution efficiency (DE),
T
50 and
T
90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of
T
50 and
T
90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50
rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2009.11.022</identifier><identifier>PMID: 19941944</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Biological and medical sciences ; Buffers ; Chemistry, Pharmaceutical ; Delayed-Action Preparations ; Diclofenac - chemistry ; Dissolution assay ; Dissolution kinetics ; Drug Carriers ; General pharmacology ; Hardness ; Hydrogen-Ion Concentration ; Hypromellose ; Hypromellose Derivatives ; Kinetics ; Medical sciences ; Methylcellulose - analogs & derivatives ; Methylcellulose - chemistry ; Models, Chemical ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Sodium diclofenac ; Solubility ; Tablets ; Technology, Pharmaceutical - methods ; Temperature</subject><ispartof>International journal of pharmaceutics, 2010-02, Vol.386 (1), p.201-207</ispartof><rights>2009</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22475210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19941944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mourão, Samanta C.</creatorcontrib><creatorcontrib>da Silva, Cristiane</creatorcontrib><creatorcontrib>Bresolin, Tania M.B.</creatorcontrib><creatorcontrib>Serra, Cristina H.R.</creatorcontrib><creatorcontrib>Porta, Valentina</creatorcontrib><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37
°C using apparatus II at 50, 75 or 100
rpm. Dissolution efficiency (DE),
T
50 and
T
90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of
T
50 and
T
90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50
rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Biological and medical sciences</subject><subject>Buffers</subject><subject>Chemistry, Pharmaceutical</subject><subject>Delayed-Action Preparations</subject><subject>Diclofenac - chemistry</subject><subject>Dissolution assay</subject><subject>Dissolution kinetics</subject><subject>Drug Carriers</subject><subject>General pharmacology</subject><subject>Hardness</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hypromellose</subject><subject>Hypromellose Derivatives</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Methylcellulose - analogs & derivatives</subject><subject>Methylcellulose - chemistry</subject><subject>Models, Chemical</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Sodium diclofenac</subject><subject>Solubility</subject><subject>Tablets</subject><subject>Technology, Pharmaceutical - methods</subject><subject>Temperature</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkE1v1TAQRS0Eoo_CTwBlg7pKGH_ETlYIlVKQKiFVZW3NsyfUT0n8sB1E_z2pXgTLrmZz7p2rw9hbDg0Hrj8cmnA43mOaGgHQN5w3IMQztuOdkbVURj9nO5Cmq1tu5Bl7lfMBALTg8iU7432veK_Ujt1-DjnHcSkhztURE05UKOVqiKnK0YdlqnxwYxxoRle7OBcMc5h_VvcPxxQnGseYqZqwpPCnKrgfqbxmLwYcM73Z7jn78eXq7vJrffP9-tvlp5vayV6VugdBgoZWc1QetNYGUQo_dEYDAmlQQsgWBmr30GnX806hVtRz77XRwslzdnHqXYf8WigXO4Xs1kU4U1yyNVJ2WhrRrWR7Il2KOSca7DGFCdOD5WAfbdqD3WzaR5uWc7vaXHPvtg_LfiL_P7XpW4H3G4DZ4TgknF3I_zghlGkFh5X7eOJo9fE7ULLZBZod-ZDIFetjeGLKX5L-lmc</recordid><startdate>20100215</startdate><enddate>20100215</enddate><creator>Mourão, Samanta C.</creator><creator>da Silva, Cristiane</creator><creator>Bresolin, Tania M.B.</creator><creator>Serra, Cristina H.R.</creator><creator>Porta, Valentina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100215</creationdate><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><author>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Biological and medical sciences</topic><topic>Buffers</topic><topic>Chemistry, Pharmaceutical</topic><topic>Delayed-Action Preparations</topic><topic>Diclofenac - chemistry</topic><topic>Dissolution assay</topic><topic>Dissolution kinetics</topic><topic>Drug Carriers</topic><topic>General pharmacology</topic><topic>Hardness</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hypromellose</topic><topic>Hypromellose Derivatives</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Methylcellulose - analogs & derivatives</topic><topic>Methylcellulose - chemistry</topic><topic>Models, Chemical</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Sodium diclofenac</topic><topic>Solubility</topic><topic>Tablets</topic><topic>Technology, Pharmaceutical - methods</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mourão, Samanta C.</creatorcontrib><creatorcontrib>da Silva, Cristiane</creatorcontrib><creatorcontrib>Bresolin, Tania M.B.</creatorcontrib><creatorcontrib>Serra, Cristina H.R.</creatorcontrib><creatorcontrib>Porta, Valentina</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mourão, Samanta C.</au><au>da Silva, Cristiane</au><au>Bresolin, Tania M.B.</au><au>Serra, Cristina H.R.</au><au>Porta, Valentina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2010-02-15</date><risdate>2010</risdate><volume>386</volume><issue>1</issue><spage>201</spage><epage>207</epage><pages>201-207</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37
°C using apparatus II at 50, 75 or 100
rpm. Dissolution efficiency (DE),
T
50 and
T
90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of
T
50 and
T
90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50
rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19941944</pmid><doi>10.1016/j.ijpharm.2009.11.022</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2010-02, Vol.386 (1), p.201-207 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_733863728 |
source | ScienceDirect Journals |
subjects | Anti-Inflammatory Agents, Non-Steroidal - chemistry Biological and medical sciences Buffers Chemistry, Pharmaceutical Delayed-Action Preparations Diclofenac - chemistry Dissolution assay Dissolution kinetics Drug Carriers General pharmacology Hardness Hydrogen-Ion Concentration Hypromellose Hypromellose Derivatives Kinetics Medical sciences Methylcellulose - analogs & derivatives Methylcellulose - chemistry Models, Chemical Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Sodium diclofenac Solubility Tablets Technology, Pharmaceutical - methods Temperature |
title | Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dissolution%20parameters%20for%20sodium%20diclofenac-containing%20hypromellose%20matrix%20tablet&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Mour%C3%A3o,%20Samanta%20C.&rft.date=2010-02-15&rft.volume=386&rft.issue=1&rft.spage=201&rft.epage=207&rft.pages=201-207&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2009.11.022&rft_dat=%3Cproquest_cross%3E733863728%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733863728&rft_id=info:pmid/19941944&rfr_iscdi=true |